Skip to main content
Clinical Trials/NCT00592748
NCT00592748CompletedPhase 1

Randomized Study of Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine

Massachusetts General Hospital1 site in 1 country381 target enrollmentStarted: June 1, 1999Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
381
Locations
1
Primary Endpoint
Acute Toxicity

Study Overview

Brief Summary

The primary purpose of this study is to determine if the administration of a higher dose would decrease the chance of tumor recurrence, compared to the risk of tumor recurrence with a lower dose. Most of the treatment will be given protons, but participants may receive a small portion of treatment with x-rays, because less radiation is given to the skin with x-rays. This study uses two slightly different doses of radiation It is not clear at this time which of the dose levels is better.

Detailed Description

  • Participants will be assigned to a dose level by random chance, like flipping a coin.
  • A treatment plan will be determined by a treatment planning CT scan and will either involve 40-44 treatments or 37-40 treatments.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Biopsy proven chordoma. Slides must be reviewed prior to randomization by the central review pathologist
  • •Sites: Intercranial (sphenoid, clivus, petrous, basio-occiput) or cervical spine
  • •Boost target volume less than or equal to 150
  • •18 years of age or older
  • •Karnofsky Performance Status > 50
  • •Neurologic Function of I or II
  • •No evidence of metastases

Exclusion Criteria

  • •Previous radiation to the head or neck that would compromise the ability to deliver the prescribed treatment
  • •Concurrent or prior malignancy unless disease free for 5 or more years
  • •Evidence of metastatic disease
  • •Diabetes mellitus
  • •Major medical illness or psychiatric impairments that in the opinion of the investigator, will prevent administration or completion of the protocol therapy

Arms & Interventions

Group 2

Active Comparator

37-40 Treatments

Intervention: Charged Particle Radiation Therapy (Radiation)

Group 1

Active Comparator

40-44 Treatments

Intervention: Charged Particle Radiation Therapy (Radiation)

Outcomes

Primary Outcomes

Acute Toxicity

Time Frame: 90 days

Secondary Outcomes

  • Establish local control rates for both dose schedules.(5 years)
  • Late Toxicity(5 Years)
  • To provide date to be used as the basis for choosing the dose of charged particle radiation for chordomas of the base of skull and the cervical spine.(5 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Norbert J. Liebsch, M.D.

Director, Skull-Based Service

Massachusetts General Hospital

Study Sites (1)

Loading locations...

Similar Trials